What is Gemini?
Gemini operates as a sophisticated digital health platform designed to harmonize disparate hospital electronic health record systems. By providing a secure, privacy-preserving environment, the company enables researchers and developers to leverage high-fidelity data while strictly adhering to provincial data governance and sovereignty mandates. Its core value proposition lies in its ability to act as a trusted intermediary, allowing for the seamless flow of information necessary for AI development and clinical innovation without compromising patient confidentiality.
The platform serves as a foundational layer for modern medical research, supporting a wide array of stakeholders from academic institutions to private sector innovators. By maintaining a robust, compliant, and scalable architecture, Gemini has established itself as a critical utility in the Canadian healthcare ecosystem, facilitating the transition toward data-informed clinical decision-making and improved patient outcomes.
How much funding has Gemini raised?
Gemini has raised a total of $100M across 1 funding round:
Other Financing Round
$100M
Other Financing Round (2026): $100M with participation from Government of Canada
Key Investors in Gemini
Government of Canada
The Government of Canada serves as the primary federal authority, providing public services and resources across various sectors including healthcare, taxation, and immigration. As a strategic backer, it supports national initiatives aimed at fostering innovation and improving public health outcomes through robust digital infrastructure.
What's next for Gemini?
Looking ahead, the strategic deployment of this financing will likely focus on expanding the platform's reach across additional hospital networks and enhancing its AI-readiness. As the demand for high-quality, longitudinal health data continues to surge, Gemini is poised to play a central role in the digitization of clinical trials and the broader modernization of healthcare infrastructure. The company's commitment to maintaining rigorous data sovereignty standards will remain a key competitive advantage as it navigates the complexities of the evolving regulatory landscape. Future growth will likely be characterized by deeper integration with existing clinical workflows and the development of advanced analytical tools that empower researchers to derive deeper insights from complex health datasets.
See full Gemini company page
